Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 8 | 2024 | 45 | 4.380 |
Why?
|
| Furans | 4 | 2026 | 9 | 2.840 |
Why?
|
| Lignans | 4 | 2026 | 9 | 2.840 |
Why?
|
| Quercetin | 5 | 2024 | 9 | 1.980 |
Why?
|
| Tea | 4 | 2024 | 6 | 1.550 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 72 | 1.510 |
Why?
|
| Cell Proliferation | 7 | 2026 | 143 | 1.120 |
Why?
|
| Taxoids | 2 | 2016 | 3 | 0.940 |
Why?
|
| Cell Line, Tumor | 7 | 2026 | 156 | 0.840 |
Why?
|
| Breast Neoplasms | 1 | 2026 | 170 | 0.830 |
Why?
|
| Tumor Burden | 2 | 2020 | 19 | 0.750 |
Why?
|
| Animals | 7 | 2026 | 1875 | 0.740 |
Why?
|
| Mice | 5 | 2026 | 746 | 0.700 |
Why?
|
| Male | 8 | 2024 | 3671 | 0.650 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 4 | 0.650 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 12 | 0.650 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2026 | 38 | 0.620 |
Why?
|
| Adipose Tissue | 1 | 2020 | 69 | 0.610 |
Why?
|
| Polyphenols | 2 | 2016 | 2 | 0.590 |
Why?
|
| Inflammation | 1 | 2020 | 143 | 0.590 |
Why?
|
| Apoptosis | 4 | 2026 | 179 | 0.580 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2024 | 19 | 0.530 |
Why?
|
| Obesity | 1 | 2020 | 226 | 0.530 |
Why?
|
| Humans | 9 | 2026 | 6794 | 0.490 |
Why?
|
| Mice, SCID | 3 | 2026 | 16 | 0.470 |
Why?
|
| Receptors, Androgen | 3 | 2020 | 20 | 0.370 |
Why?
|
| Prostate | 2 | 2024 | 15 | 0.370 |
Why?
|
| Drug Synergism | 3 | 2016 | 26 | 0.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2026 | 88 | 0.350 |
Why?
|
| Chemoprevention | 2 | 2024 | 9 | 0.310 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 155 | 0.260 |
Why?
|
| MCF-7 Cells | 1 | 2026 | 15 | 0.250 |
Why?
|
| Cell Movement | 1 | 2026 | 38 | 0.240 |
Why?
|
| STAT3 Transcription Factor | 2 | 2017 | 16 | 0.240 |
Why?
|
| Tensins | 1 | 2024 | 2 | 0.210 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2024 | 6 | 0.210 |
Why?
|
| Mice, Knockout | 1 | 2024 | 150 | 0.200 |
Why?
|
| Phytochemicals | 1 | 2022 | 3 | 0.190 |
Why?
|
| Hormones | 1 | 2022 | 11 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 23 | 0.190 |
Why?
|
| Exosomes | 1 | 2022 | 7 | 0.180 |
Why?
|
| Neoplasms | 1 | 2022 | 92 | 0.160 |
Why?
|
| Adipokines | 1 | 2020 | 3 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 11 | 0.160 |
Why?
|
| Administration, Oral | 1 | 2020 | 54 | 0.160 |
Why?
|
| Adipocytes | 1 | 2020 | 31 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2020 | 53 | 0.150 |
Why?
|
| Cytokines | 1 | 2020 | 80 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 59 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 231 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2022 | 54 | 0.140 |
Why?
|
| Female | 1 | 2026 | 4060 | 0.130 |
Why?
|
| Telomerase | 1 | 2017 | 3 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 6 | 0.130 |
Why?
|
| Pyrans | 1 | 2017 | 4 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 23 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2016 | 10 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 51 | 0.120 |
Why?
|
| Catechin | 1 | 2015 | 2 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 7 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 27 | 0.110 |
Why?
|
| Androgens | 1 | 2014 | 24 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2015 | 57 | 0.110 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2013 | 1 | 0.100 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 2 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2014 | 246 | 0.100 |
Why?
|
| Ligands | 1 | 2022 | 17 | 0.050 |
Why?
|
| Models, Biological | 1 | 2022 | 64 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 3 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 12 | 0.030 |
Why?
|
| Benzamides | 1 | 2017 | 11 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 43 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 35 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 15 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 15 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 45 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 21 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 48 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 73 | 0.030 |
Why?
|